Algae as protein factories: Expression of a human antibody and the respective antigen in the diatom phaeodactylum tricornutum

PLoS ONE

Volumn 6, Issue 12, 2011, Pages

  Hempel, Franziska ^a   Lau, Julia ^a   Klingl, Andreas ^a   Maier, Uwe G ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; IMMUNOGLOBULIN G ANTIBODY; ANTIBODY; GREEN FLUORESCENT PROTEIN; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY; RECOMBINANT PROTEIN;

ANTIBODY PRODUCTION; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; DIATOM; NONHUMAN; PHAEODACTYLUM TRICORNUTUM; PROTEIN EXPRESSION; BIOCHEMISTRY; CELL LINE; CHEMISTRY; CODON; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE MICROSCOPY; HUMAN; METABOLISM; METHODOLOGY; MICROALGA; PHYSIOLOGY; PLASMID; PROTEIN ENGINEERING;

ANTIBODIES; ANTIBODIES, MONOCLONAL; BIOCHEMISTRY; CELL LINE; CODON; DIATOMS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GREEN FLUORESCENT PROTEINS; HEPATITIS B SURFACE ANTIGENS; HUMANS; IMMUNOGLOBULIN G; MICROALGAE; MICROSCOPY, FLUORESCENCE; PLASMIDS; PROTEIN ENGINEERING; RECOMBINANT PROTEINS;

EID: 82555187161     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0028424     Document Type: Article

References (51)

1. Potvin G, Zhang Z, (2010) Strategies for high-level recombinant protein expression in transgenic microalgae: a review. Biotechnol Adv 28: 910-918.
2. Chisti Y, (2007) Biodiesel from microalgae. Biotechnol Adv 25: 294-306.
3. Stephens E, Ross IL, King Z, Mussgnug JH, Kruse O, et al. (2010) An economic and technical evaluation of microalgal biofuels. Nat Biotechnol 28: 126-128.
4. Wijffels RH, Barbosa MJ, (2010) An outlook on microalgal biofuels. Science 329: 796-799.
5. Walker TL, Purton S, Becker DK, Collet C, (2005) Microalgae as bioreactors. Plant Cell Rep 24: 629-641.
6. Raja R, Hemaiswarya S, Kumar NA, Sridhar S, Rengasamy R, (2008) A perspective on the biotechnological potential of microalgae. Crit Rev Microbiol 34: 77-88.
7. Falkowski PG, Barber RT, Smetacek VV, (1998) Biogeochemical Controls and Feedbacks on Ocean Primary Production. Science 281: 200-207.
8. Field CB, Behrenfeld MJ, Randerson JT, Falkowski P, (1998) Primary production of the biosphere: integrating terrestrial and oceanic components. Science 281: 237-240.
9. Bozarth A, Maier UG, Zauner S, (2009) Diatoms in biotechnology: modern tools and applications. Appl Microbiol Biotechnol 82: 195-201.
10. Hempel F, Bozarth AS, Lindenkamp N, Klingl A, Zauner S, et al. (2011) Microalgae as bioreactors for bioplastic production. Microb Cell Fact 10: 81.
11. Köhler G, Milstein C, (1975) Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256: 495-497.
12. Verma R, Boleti E, George AJ, (1998) Antibody engineering: comparison of bacterial, yeast, insect and mammalian expression systems. J Immunol Methods 216: 165-181.
13. Chadd HE, Chamow SM, (2001) Therapeutic antibody expression technology. Curr Opin Biotechnol 12: 188-194.
14. De Muynck B, Navarre C, Boutry M, (2010) Production of antibodies in plants: status after twenty years. Plant Biotechnol J 8: 529-563.
15. Decker EL, Reski R, (2008) Current achievements in the production of complex biopharmaceuticals with moss bioreactors. Bioprocess Biosyst Eng 31: 3-9.
16. Tran M, Zhou B, Pettersson PL, Gonzalez MJ, Mayfield SP, (2009) Synthesis and assembly of a full-length human monoclonal antibody in algal chloroplasts. Biotechnol Bioeng 104: 663-673.
17. Mayfield SP, Franklin SE, (2005) Expression of human antibodies in eukaryotic micro-algae. Vaccine 23: 1828-1832.
18. Lavanchy D, (2004) Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat 11: 97-107.
19. Milich DR, (1997) Pathobiology of acute and chronic hepatitis B virus infection: an introduction. J Viral Hepat 4 (Suppl 2): 25-30.
20. Valenzuela P, Medina A, Rutter WJ, Ammerer G, Hall BD, (1982) Synthesis and assembly of hepatitis B virus surface antigen particles in yeast. Nature 298: 347-350.
21. McAleer WJ, Buynak EB, Maigetter RZ, Wampler DE, Miller WJ, et al. (1984) Human hepatitis B vaccine from recombinant yeast. Nature 307: 178-180.
22. Yano A, Maeda F, Takekoshi M, (2004) Transgenic tobacco cells producing the human monoclonal antibody to hepatitis B virus surface antigen. J Med Virol 73: 208-215.
23. Maeda F, Nagatsuka Y, Ihara S, Aotsuka S, Ono Y, et al. (1999) Bacterial expression of a human recombinant monoclonal antibody fab fragment against hepatitis B surface antigen. J Med Virol 58: 338-345.
24. Walsh G, Jefferis R, (2006) Post-translational modifications in the context of therapeutic proteins. Nat Biotechnol 24: 1241-1252.
25. Hempel F, Bullmann L, Lau J, Zauner S, Maier UG, (2009) ERAD-derived preprotein transport across the second outermost plastid membrane of diatoms. Mol Biol Evol 26: 1781-1790.
26. Patzer EJ, Nakamura GR, Simonsen CC, Levinson AD, Brands R, (1986) Intracellular assembly and packaging of hepatitis B surface antigen particles occur in the endoplasmic reticulum. J Virol 58: 884-892.
27. Biemans R, Thines D, Petre-Parent B, De Wilde M, Rutgers T, et al. (1992) Immunoelectron microscopic detection of the hepatitis B virus major surface protein in dilated perinuclear membranes of yeast cells. DNA Cell Biol 11: 621-626.
28. Sojikul P, Buehner N, Mason HS, (2003) A plant signal peptide-hepatitis B surface antigen fusion protein with enhanced stability and immunogenicity expressed in plant cells. Proc Natl Acad Sci U S A 100: 2209-2214.
29. Mason HS, Lam DM, Arntzen CJ, (1992) Expression of hepatitis B surface antigen in transgenic plants. Proc Natl Acad Sci U S A 89: 11745-11749.
30. Dogan B, Mason HS, Richter L, Hunter JB, Shuler ML, (2000) Process options in hepatitis B surface antigen extraction from transgenic potato. Biotechnol Prog 16: 435-441.
31. Richter LJ, Thanavala Y, Arntzen CJ, Mason HS, (2000) Production of hepatitis B surface antigen in transgenic plants for oral immunization. Nat Biotechnol 18: 1167-1171.
32. Chiba Y, Jigami Y, (2007) Production of humanized glycoproteins in bacteria and yeasts. Curr Opin Chem Biol 11: 670-676.
33. Chu L, Robinson DK, (2001) Industrial choices for protein production by large-scale cell culture. Curr Opin Biotechnol 12: 180-187.
34. Fischer R, Emans N, (2000) Molecular farming of pharmaceutical proteins. Transgenic Res 9: 279-299; discussion 277.
35. Goddijn OJM, Pen J, (1995) Plants as bioreactors. Trends in Biotechnology 13: 379-387.
36. Twyman RM, Stoger E, Schillberg S, Christou P, Fischer R, (2003) Molecular farming in plants: host systems and expression technology. Trends Biotechnol 21: 570-578.
37. Daniell H, Singh ND, Mason H, Streatfield SJ, (2009) Plant-made vaccine antigens and biopharmaceuticals. Trends Plant Sci 14: 669-679.
38. Fischer R, Stoger E, Schillberg S, Christou P, Twyman RM, (2004) Plant-based production of biopharmaceuticals. Curr Opin Plant Biol 7: 152-158.
39. Ma JK, Drake PM, Christou P, (2003) The production of recombinant pharmaceutical proteins in plants. Nat Rev Genet 4: 794-805.
40. Mayfield SP, Manuell AL, Chen S, Wu J, Tran M, et al. (2007) Chlamydomonas reinhardtii chloroplasts as protein factories. Curr Opin Biotechnol 18: 126-133.
41. Morweiser M, Kruse O, Hankamer B, Posten C, (2010) Developments and perspectives of photobioreactors for biofuel production. Appl Microbiol Biotechnol 87: 1291-1301.
42. Ugwu CU, Aoyagi H, Uchiyama H, (2008) Photobioreactors for mass cultivation of algae. Bioresour Technol 99: 4021-4028.
43. Ramirez N, Rodriguez M, Ayala M, Cremata J, Perez M, et al. (2003) Expression and characterization of an anti-(hepatitis B surface antigen) glycosylated mouse antibody in transgenic tobacco (Nicotiana tabacum) plants and its use in the immunopurification of its target antigen. Biotechnol Appl Biochem 38: 223-230.
44. De Muynck B, Navarre C, Nizet Y, Stadlmann J, Boutry M, (2009) Different subcellular localization and glycosylation for a functional antibody expressed in Nicotiana tabacum plants and suspension cells. Transgenic Res 18: 467-482.
45. Komarnytsky S, Borisjuk N, Yakoby N, Garvey A, Raskin I, (2006) Cosecretion of protease inhibitor stabilizes antibodies produced by plant roots. Plant Physiol 141: 1185-1193.
46. Sharp JM, Doran PM, (2001) Strategies for enhancing monoclonal antibody accumulation in plant cell and organ cultures. Biotechnol Prog 17: 979-992.
47. Bruss V, Gerhardt E, Vieluf K, Wunderlich G, (1996) Functions of the large hepatitis B virus surface protein in viral particle morphogenesis. Intervirology 39: 23-31.
48. Fujisawa Y, Ito Y, Sasada R, Ono Y, Igarashi K, et al. (1983) Direct expression of hepatitis B surface antigen gene in E. coli. Nucleic Acids Res 11: 3581-3591.
49. Guan ZJ, Guo B, Huo YL, Guan ZP, Wei YH, (2010) Overview of expression of hepatitis B surface antigen in transgenic plants. Vaccine 28: 7351-7362.
50. Kumar GB, Ganapathi TR, Revathi CJ, Srinivas L, Bapat VA, (2005) Expression of hepatitis B surface antigen in transgenic banana plants. Planta 222: 484-493.
51. Apt KE, Kroth-Pancic PG, Grossman AR, (1996) Stable nuclear transformation of the diatom Phaeodactylum tricornutum. Mol Gen Genet 252: 572-579.